FDA Clearance Tracker · P020014-S047
Essure System for Permanent Birth Control (Model ESS305)
Last checked: Nov 20, 2026Latest source record: Sep 29, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Sep 29, 2016
Approved
Time to decision
62 days
Received Jul 29, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P020014-S047
- Device name
- Essure System for Permanent Birth Control (Model ESS305)
- Applicant
- Bayer Pharma AG
- Applicant location
- Berlin
- Received
- Jul 29, 2016
- Decided
- Sep 29, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P020014
Device type
- Device class
- Class III
- Regulation
- 21 CFR 884.5380
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
Approval of changes to the post-approval protocol.
Source documents
Other decisions for Bayer Pharma AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.